Back
Atomera, Inc. 10K Form
Sell
34
ATOM
Atomera, Inc.
Last Price:
$2.50
Seasonality Move:
46.77%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-01 | 10Q | ATOM/Atomera, Inc. Quarterly |
| 2023-08-02 | 10Q | ATOM/Atomera, Inc. Quarterly |
| 2023-04-26 | 10Q | ATOM/Atomera, Inc. Quarterly |
| 2022-11-09 | 10Q | ATOM/Atomera, Inc. Quarterly |
| 2022-08-02 | 10Q | ATOM/Atomera, Inc. Quarterly |
| 2022-04-27 | 10Q | ATOM/Atomera, Inc. Quarterly |
Receive ATOM News And Ratings
See the #1 stock for the next 7 days that we like better than ATOM
ATOM Financial Statistics
Sales & Book Value
| Annual Sales: | $135K |
|---|---|
| Cash Flow: | $-3.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.60 |
| Price / Book: | 4.15 |
Profitability
| EPS (TTM): | -0.67560 |
|---|---|
| Net Income (TTM): | $-20.4M |
| Gross Margin: | $-1.4M |
| Return on Equity: | -97.57% |
| Return on Assets: | -83.67% |
Atomera, Inc. Earnings Forecast
Key Atomera, Inc. Financial Ratios
-
The Gross Profit Margin over the past 9 years for ATOM is -1,002.22%.
-
The Selling, General & Administrative Expenses for ATOM have been equal to 6,162.22% of Gross Profit Margin.
-
The Research & Development expenses have been 8,129.63% of Revenue.
-
The Net Earning history of ATOM is -13,655.56% of Total Revenues.
-
Per Share Earnings over the last 11 years have been positive in 6 years.
Atomera, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Semiconductors & Semiconductor Equipment |
| Sector: | Information Technology |
| Current Symbol: | ATOM |
| CUSIP: | 04965B |
| Website: | atomera.com |
Debt
| Debt-to-Equity Ratio: | 0.04 |
|---|---|
| Current Ratio: | 7.23 |
| Quick Ratio: | 7.03 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ATOM Technical Analysis vs Fundamental Analysis
Sell
34
Atomera, Inc. (ATOM)
is a Sell
Is Atomera, Inc. a Buy or a Sell?
-
Atomera, Inc. stock is rated a SellThe current Atomera, Inc. [ATOM] share price is $2.49. The Score for ATOM is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.